ID | 118380 |
Title Alternative | プロテアソーム阻害薬による骨髄腫骨病変部における優先的な骨形成のメカニズムについて
|
Author |
Nakaue, Emiko
Tokushima University
Teramachi, Jumpei
Okayama University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Hiasa, Masahiro
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Oda, Asuka
Tokushima University
Inoue, Yusuke
Tokushima University
Higa, Yoshiki
Tokushima University
Maruhashi, Tomoko
Tokushima University
Endo, Itsuro
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Tanaka, Eiji
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Abe, Masahiro
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
|
Keywords | Osteoblast
Osteoclast
Proteasome inhibitor
Pulsatile treatment
Multiple myeloma
|
Content Type |
Thesis or Dissertation
|
Description | Proteasome inhibitors (PIs) can preferentially restore bone in bone-defective lesions of patients with multiple myeloma (MM) who respond favorably to these drugs. Most prior in vitro studies on PIs used continuous exposure to low PI concentrations, although pharmacokinetic analysis in patients has shown that serum concentrations of PIs change in a pulsatile manner. In the present study, we explored the effects of pulsatile treatment with PIs on bone metabolism to simulate in vivo PI pharmacokinetics. Pulsatile treatment with bortezomib, carfilzomib, or ixazomib induced MM cell death but only marginally affected the viability of osteoclasts (OCs) with F-actin ring formation. Pulsatile PI treatment suppressed osteoclastogenesis in OC precursors and bone resorption by mature OCs. OCs robustly enhanced osteoblastogenesis in cocultures with OCs and MC3T3-E1 pre-osteoblastic cells, indicating OC-mediated coupling to osteoblastogenesis. Importantly, pulsatile PI treatment did not impair robust OC-mediated osteoblastogenesis. These results suggest that PIs might sufficiently reduce MM cell-derived osteoblastogenesis inhibitors to permit OC-driven bone formation coupling while suppressing OC differentiation and activity in good responders to PIs. OC-mediated coupling to osteoblastogenesis appears to be a predominant mechanism for preferential occurrence of bone regeneration at sites of osteoclastic bone destruction in good responders.
|
Journal Title |
International Journal of Hematology
|
ISSN | 09255710
18653774
|
NCID | AA10797094
|
Publisher | Springer Nature
|
Volume | 118
|
Issue | 1
|
Start Page | 88
|
End Page | 98
|
Published Date | 2023-04-11
|
Remark | 内容要旨・審査要旨・論文本文の公開
本論文は,著者Emiko Nakaueの学位論文として提出され,学位審査・授与の対象となっている。 This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use (https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms), but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1007/s12185-023-03601-2 |
EDB ID | |
DOI (Published Version) | |
URL ( Publisher's Version ) | |
FullText File | |
language |
eng
|
TextVersion |
ETD
|
MEXT report number | 甲第3741号
|
Diploma Number | 甲口第497号
|
Granted Date | 2023-06-08
|
Degree Name |
Doctor of Dental Science
|
Grantor |
Tokushima University
|
departments |
Oral Sciences
University Hospital
Medical Sciences
|